Kesimpta 20 mg/0.4 mL prefilled Sensoready Pen Images
Generic Name: ofatumumab
This medication has been identified as Kesimpta 20 mg/0.4 mL prefilled Sensoready Pen. It is supplied by Novartis Pharmaceuticals Corporation.
Kesimpta is used in the treatment of Multiple Sclerosis and belongs to the drug classes CD20 monoclonal antibodies, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Kesimpta 20 mg/0.4 mL prefilled Sensoready Pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Kesimpta
- Generic Name
- ofatumumab
- Strength
- 20 mg/0.4 mL prefilled Sensoready Pen
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies, Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-1007
More about Kesimpta (ofatumumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (73)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.